Clinical Trials: Antirheumatic Agents
- Abatacept 94 studies
- Aceclofenac 2 studies
- Acetaminophen, hydrocodone drug combination 28 studies
- Acetovanillone 2 studies
- Acetylsalicylic acid lysinate 3 studies
- Adalimumab 248 studies
- Adapalene 51 studies
- Allopurinol 93 studies
- Andrographolide 1 study
- Anti-Inflammatory Agents, Non-Steroidal 2426 studies
- Arthrotec 1 study
- Aspirin 581 studies
- Balsalazide 7 studies
- Benzbromarone 1 study
- Betulinic acid 1 study
- Borage oil 5 studies
- Boswellic acid 1 study
- Bromfenac 35 studies
- Bucillamine 1 study
- Carbon fiber 4 studies
- Celecoxib 302 studies
- Chloroquine diphosphate 84 studies
- Choline magnesium trisalicylate 2 studies
- Clofazimine 11 studies
- Clonixin 1 study
- CNI 1493 5 studies
- Colchicine 63 studies
- Curcumin 66 studies
- Dan-shen root extract 2 studies
- Dexketoprofen trometamol 2 studies
- Diclofenac 160 studies
- Diclofenac hydroxyethylpyrrolidine 9 studies
- Diflunisal 3 studies
- Dipyrone 12 studies
- Ebselen 4 studies
- Efamol 9 studies
- Etodolac 9 studies
- Etoricoxib 74 studies
- Febuxostat 20 studies
- Ferulic acid 1 study
- Flurbiprofen 15 studies
- Flurbiprofen axetil 2 studies
- Higenamine 1 study
- Ibuprofen 225 studies
- Icatibant 12 studies
- Indobufen 2 studies
- Indomethacin 56 studies
- Infliximab 218 studies
- Ketoprofen 38 studies
- Ketorolac 144 studies
- Ketorolac Tromethamine 144 studies
- Leflunomide 35 studies
- Lipoxin A4 1 study
- Lisofylline 2 studies
- Lornoxicam 7 studies
- Loxoprofen 4 studies
- Lumiracoxib 17 studies
- Magnesium Salicylate 3 studies
- Mefenamic Acid 2 studies
- Meloxicam 27 studies
- Mesalamine 104 studies
- Methyl salicylate 2 studies
- Nabumetone 4 studies
- Nafamostat 2 studies
- Naproxen 179 studies
- Nimesulide 3 studies
- Nitroaspirin 3 studies
- Nordihydroguaiaretic Acid 8 studies
- Olopatadine 37 studies
- Olsalazine 1 study
- Palmidrol 3 studies
- Parecoxib 23 studies
- Parthenolide 3 studies
- Pimecrolimus 56 studies
- Pirfenidone 17 studies
- Piroxicam 9 studies
- Probenecid 21 studies
- Pyranoprofen 2 studies
- Rasburicase 22 studies
- Resveratrol 43 studies
- Rifamycin SV 7 studies
- Rituximab 1108 studies
- Rofecoxib 30 studies
- Rosmarinic acid 2 studies
- Salicylates 26 studies
- Salicylsalicylic acid 20 studies
- Sodium Salicylate 20 studies
- Sulfasalazine 28 studies
- Sulindac 33 studies
- Sulindac sulfone 12 studies
- Tanshinone 1 study
- Tinoridine 1 study
- TNFR-Fc fusion protein 246 studies
- Tranilast 9 studies
- Uricosuric Agents 25 studies
- Valdecoxib 29 studies
- Zileuton 16 studies
- 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid 1 study
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://www.clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_ARhu
